Fox Chase Cancer Center News

PHILADELPHIA (September 28, 2012)—Fox Chase Cancer Center has been selected by the Association of Community Cancer Centers (ACCC)—the leading national multidisciplinary organization that sets the standard for quality care for patients with cancer—to receive a 2012 ACCC Innovator Award, sponsored by GE Healthcare.  The award, which will be given at the ACCC 29th National Oncology Conference in early October, honors ACCC-member cancer programs that have exhibited forward-thinking strategic planning and developed pioneering programs and replicable models.

PHILADELPHIA (September 20, 2012)—Temple University School of Medicine and Fox Chase Cancer Center will hold the first Temple Biomedical Research Day on Friday, September 21, 2012 to showcase research and programs at both institutions. A cadre of Temple and Fox Chase researchers will receive awards and give presentations, while more than 150 postdoctoral researchers and graduate students will fill a building lobby with poster displays of their research.

PHILADELPHIA (September 20, 2012)—The Tyanna Foundation, a volunteer-run organization dedicated to improving the lives of breast cancer patients, is hosting the third annual BreastFest Philly on Saturday, September 29 from 3:00 to 8:00 p.m. at Mad River Bar & Grille (4100 Main Street in Manayunk). BreastFest is the foundation’s flagship event and has raised over one million dollars for breast cancer awareness, research, services, education, treatment and patient care.

PHILADELPHIA (August 2, 2012)—The Risk Assessment Program at Fox Chase Cancer Center, part of the Center’s Department of Clinical Genetics, has a new educational website available to help patients understand the personal and family risk factors that may put them at higher risk for cancer. By utilizing the website, patients and their family members can learn about their risk factors and what they can do to lower their chances of getting cancer.

Philadelphia (August 1, 2012)—Three hospitals from Fox Chase Cancer Center Partners—Fox Chase’s affiliate network of community hospitals—have qualified to take part in the National Comprehensive Cancer Network® (NCCN®) Affiliate Research Project (ARP). Developed by the NCCN Oncology Research Program (ORP), the project is dedicated to improving patient outcomes and advancing clinical research through collaboration among NCCN; the 21 NCCN member institutions, including Fox Chase Cancer Center; and their community-based affiliate networks.

PHILADELPHIA (July 17, 2012)—Fox Chase Cancer Center has been listed among the top 50 cancer hospitals in the nation in U.S. News & World Report’s annual Best Hospitals rankings, with nephrology designated as a high-performing specialty area. The Center also ranked 6th among all hospitals in the Philadelphia metropolitan area.

(Philadelphia, PA) – As of July 1, 2012, Fox Chase Cancer Center became a part of Temple University Health System, one of Philadelphia’s leading academic health centers, providing access to quality care through its hospitals and multi-specialty satellite facilities while supporting excellence and innovation in education and research.   

PHILADELAPHIA, PA (June 26, 2012)—Surgery and radiation therapy are the two most common forms of treatment for newly diagnosed, non-metastatic prostate cancer. Now, an entirely new treatment for prostate cancer is under investigation at Fox Chase Cancer Center—a vaccine therapy called ProstAtak™.